This study, sponsored by Istanbul University, aims to enhance diagnostic capabilities in Alzheimer's Disease through a novel semantic recognition task. The focus on early-stage Alzheimer's patients may provide valuable insights into semantic processing deficits, potentially leading to improved clinical assessments and interventions. The market for Alzheimer's diagnostics is expanding, driven by increasing prevalence and demand for early detection methods. The findings could position Istanbul University as a key player in the Alzheimer's research landscape, attracting partnerships and funding opportunities. However, the absence of FDA regulation and the study's academic nature may limit immediate commercial applications.